This is an automatically translated article.
Fenostad 67 is manufactured and distributed by LD Stada Co., Ltd. To learn more about what Fenostad is, its uses and how to use it effectively,... Please read through the article below.
1. What is Fenostad 67mg?
Fenofibrate medicine 67mg with the main ingredient is Fenofibrate in the form of fenofibrate pellets 66.0%. The drug is used to treat lipid disorders, severe hypertriglyceridemia and mixed hyperlipidemia... Significantly improves the distribution of cholesterol in the plasma.
2. Indications and contraindications of the drug Fenostad
Fenostad 67 is indicated for use in combination with diet, lipid-lowering treatment but without drugs in specific cases such as:
Cases with or without HDL cholesterol when the concentration of Triglycerides in the blood increases. . In case of combined hyperlipidemia when contraindicated / body does not respond to Statins. Cases of combined hyperlipidemia in people at risk for cardiovascular diseases. Combined use with 1 Statin but not control the concentration of Triglyceride, HDL Cholesterol in the blood. Contraindications to drug use:
Hypersensitivity, Allergy to the drug components Fenofibrate Severe renal failure; Liver dysfunction; Gallbladder disease; Children under 10 years old; Women who are in pregnancy; Exclusive breastfeeding; There is an allergic reaction to light during treatment with Fibrates or with Ketoprofen.
3. How to take fenostad 67 mg
How to use:
Fenostad 67 is used orally. Combine with diet and take the drug with the main meal, take the tablet whole with a glass of water. Dosage and duration of use as directed by your doctor and pharmacist. Dosage of Fenostad 67 mg:
Adults The recommended dose is 200mg/day (1 tablet x 3 times/day).
If necessary, the dose can be adjusted up to 267mg / day (1 Fenostad 67 x 4 times / day) and is not recommended when combined with Statins.
People over 65 years old In case of elderly people from 65 years old, no dose adjustment is required. For patients with renal impairment, the recommended dose is required.
Severe renal impairment The drug is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m2). Dosage should not exceed 100 mg or 67 mg Micronized once daily (eGFR 30 - 59 mL/min/1.73 m2). Immediately discontinue use of Fenofibrate if during treatment eGFR falls to < 30 mL/min/1.73 m2.
Hepatic impairment: Fenostad should not be used in patients with hepatic impairment, as safety and efficacy data are not available.
Children The recommended dose is 1 tablet of Fenofibrate 67 mg, Micronized/day/20 kg body weight.
Management of missed dose:
When you miss a dose, take the medicine as soon as you remember it. However, if it is almost time for the next dose, the missed dose can be skipped. Do not take a double dose if you miss a dose. Overdose treatment:
Currently, there are no reports of overdose and no specific antidote. However, if drug overdose is suspected, appropriate supportive measures should be used when necessary. If you have a serious reaction, contact 115 medical center or go to the nearest medical facility.
4. Some notes when taking medicine
Patients with type 2 diabetes, hypothyroidism, alcoholism, nephrotic syndrome,... should be fully treated before taking Fenofibrate. When symptoms such as jaundice, pruritus, hepatitis appear, fenofibrate should be discontinued and confirmed by laboratory tests. Pancreatic diseases or pancreatitis have been reported. When symptoms of myalgia, myositis, muscle weakness, etc. appear obvious, the drug should be stopped immediately. Concomitant use with another Fibrate or an HMG-CoA reductase inhibitor carries a risk of myotoxicity. Do not use in severe renal failure. Use with caution in patients with mild to moderate renal impairment. Discontinue when creatinine level is more than 50% of normal. For children, only early treatment of genetic diseases identified by genetic and laboratory studies is required. Start treatment when there is a scientific diet for at least 3 months. This medicine should not be used in patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency. During pregnancy, the benefits and risks of drug use should be carefully evaluated. Do not use the drug while breastfeeding.
5. Drug interactions
Based on the results of clinical studies, Fenostad 67mg may have several interactions with specific drugs:
Concomitant use of HMG CoA Reductase inhibitors may increase the risk of muscle damage and pancreatitis grant. Combined use of Cyclosporin may increase the risk of muscle damage. Concomitant use of anticoagulants poses a risk of bleeding. Combination of MAO inhibitors, Perhexiline maleate,... can cause liver toxicity. Changes in the pharmacokinetics of drugs metabolized by Cyp2C19 and Cyp2A6. To ensure the absolute effectiveness and safety when using Fenostad 67mg, you should inform your doctor about other drugs you are using, and your current health status.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
